GH Research (GHRS) News
NASDAQ: GHRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.53-1.03 (-5.55%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
GHRS news summary
We found 3 recent headlines mentioning GH Research (GHRS): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Seeking Alpha. GHRS is making an outsized move today, down 5.55% at $17.53, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "GH Research GAAP EPS of -$0.18 beats by $0.13", was published by Seeking Alpha on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest GH Research headlines
- GH Research GAAP EPS of -$0.18 beats by $0.13Seeking Alpha
- GH Research Reports Third Quarter 2026 Financial Results and Provides Business UpdateDUBLIN, Nov. 13, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing…GlobeNewswire
- GH Research Announces Appointment of Vanina Popova, MD, as Chief Development OfficerDUBLIN, Nov. 13, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing…GlobeNewswire